Polymorphism of the Pfcrt Gene and Epidemiological Characteristics in Patients with Uncomplicated Malaria at the CSU-COM Hospital of Riviera Palmeraie (Abidjan)
DOI:
https://doi.org/10.14738/aivp.104.12886Keywords:
Key words: pfcrt, Apo I, Plasmodium falciparum, Côte d'Ivoire.Abstract
Although recent data has shown a reduction by halve of malaria-related deaths, over the last three years controlling or even eliminating malaria remains a real challenge. In 2004, the high prevalence of isolates carrying the pcfrt-76T mutant allele led to the discontinuation of the use of chloroquine (CQ) as an antimalarial. Several years after its withdrawal, there is growing talk of a re-emergence of CQ sensitivity. The aim of this study was to monitor alleles of the pfcrt gene, a molecular marker of CQ resistance (CQ-R). A descriptive prospective study was conducted from September to August 2020 at the Community Health Center of Riviera Palmeraie, Abidjan (CSU-COM). One hundred and twenty (120) blood samples were collected from patients with uncomplicated P. falciparum malaria, dried on Whatman 3MM paper for 48 hours at laboratory temperature. After DNA extraction with Chelex® 100, nested PCR and enzymatic digestion with Apo I were used to demonstrate the restriction polymorphism of the pfcrt gene at codon 76. A prevalence of 16% was observed for the mutant pfcrt-76T allele, responsible for chloroquine resistance, compared with 84% for the wild-type pfcrt-K76 allele. This study highlighted a decrease in Plasmodium falciparum isolates carrying the chloroquine resistance allele, thus confirming previous data on CQ-R in Côte d'Ivoire.
References
REFERENCES
. Konaté, A., Gnagne, A.P., Bédia-Tanoh, A.V., Amiah-Droh, M., Tano, K.D., Menan E.I.H., Yavo, W., 2018. Low rates of Plasmodium falciparum Pfcrt K76T mutation in three sentinel sites of malaria monitoring in Côte d’Ivoire. Acta Parasitologica, 63(4): 795-801.
. Djaman, J., Ahibo, H., Yapi, H.F., Bla, K.B., Ouattara, L., Yavo, W., N’guessan J.D., Yapo, A., Mazabraud A., 2010. Molecular monitoring of Plasmodium falciparum malaria isolates in Côte d’Ivoire: genetic markers (dhfr-ts, dhps, pfcrt, pfmdr-1) for antimalarial-drugs resistance. European Journal of Scientific Research, 40:461-470.
. Ouattara, L., Bla, K.B., Assi, S.B., Yavo, W., Djaman, A.J., 2010. pfcrt and dhfr-ts sequences for monitoring drug resistance in Adzopé Area of Côte d’Ivoire after the withdrawal of chloroquine and pyrimethamine. Tropical Journal of Pharmaceutical Research, 9 :568.
. Dagnogo, O., Ako, A.B., Ouattara, L., Dago, D.N., Coulibaly, N.D., Touré, A.O., Djaman, A.J., 2018. Towards a re-emergence of chloroquine sensitivity in Côte d’Ivoire. Malaria Journal, 17 : 413.
. Ako, B.A., Touré OA., Johansson M., Penali L.K., Nguetta S.P.A., Sibley, C.H., 2012.
Molecular analysis of markers associated with chloroquine and sulfadoxine/pyrimethamine
Resistance in Plasmodium falciparum malaria parasites from southeastern Côte-d’Ivoire by the time
of artemisinin-based combination therapy adoption in 2005. Infection and drug resistance, 5:113.
. Yavo, W., Konaté, A., Kassi, F.K., Djohan, V., 2015. Efficacy and Safety of Artesunate
Amodiaquine versus Artéméther Lumefantrine in the Treat¬ment of Uncomplicated Plasmodium
falciparum malaria in Sentinel Sites across Côte d’Ivoire. Malaria Research and Treatment.
: 1-8.
. Phyo, A.P., Nkhoma, S., Stepniewska, K., Ashley, E.A., Nair, S., McGready R et al. 2012. Emergence of artemisinin-resistant malaria on the western border of Thailand: a longitudinal study. Lancet, 379 (9830) :1960-1966.
. Chandra, R.S., Orazem, J., Ubben, D., Duparc, S., Robbins, J., Vandenbroucke, P., 2013. Creative solutions to extraordinary challenges in clinical trials: methodology of a phase III trial of azithromycin and chloroquine fixed-dose combination in pregnant women in Africa. Malaria Journal, 12:122.
. Hand, C.C., Meshnick, S.R., 2011. Is chloroquine making a comeback? The Journal of Infectious Diseases, 203 (1):11-12.
. Mwai L, Ochong E, Abdirahman A, Kiara SM, Ward S, Kokwaro G et al. 2009. Chloroquine resistance before and after its withdrawal in Kenya. Malaria Journal, 8 :106.
. Laufer, M.K., Takala-Harrison S., Dzinjalamala, F.K., Stine, O.C., Taylor, T.E, Plowe, C.V., 2010. Return of chloroquine-susceptible falciparum malaria in Malawi was a reexpansion of diverse susceptible parasites. The Journal of Infectious Diseases, 202 (5):801-808.
. Meo, S.A., Klonoff, D.C., Akram, J., 2020. Efficacy of chloroquine and hydroxychloroquine
in the treatment of COVID-19. European Review for Medical and Pharmacological Sciences, 24
(8): 4539-4547.
. INS., 2014.- Institut National de la Statistique. Recensement général de la population et de
l’habitat, 12p.
. Basco, L.K., Ringwald, P., 2001. Analysis of the Key pfcrt Point Mutation and in vitro and in vivo response to chloroquine in Yaounde´, Cameroon. The Journal of Infectious Diseases, 183:1828-1831.
. Fidock, D. A., T. Nomura, A. K. Talley, R. A. Cooper, S. M. Dzekunov, M. T. Ferdig, L. M. Ursos, A. B. Sidhu, B. Naude, K. W. Deitsch, X. Z. Su, J. C. Wootton, P. D. Roepe, and T. E. Wellems. 2000. Mutations in the P. falciparum digestive vacuole transmembrane protein PfCRT and evidence for their role in chloroquine resistance. Mol. Cell 6:861–871.
. Fidock, D.A., Nomura, T., Talley, A.K., Cooper, R.A., Dzekunov, S.M., Ferdig, M.T., Ursos,
L.M., Sidhu, A.B., Naude, B., Deitsch, K.W., Su, X.Z., Wootton, J.C., Roepe, P.D.,Wellems, T.E., 2000. Mutations in the P. falciparum digestive vacuole transmembrane protein PfCRT and evidence for their role in chloroquine resistance. Molecular Cell. 6 (4): 861-871.
. Ouédraogo, L.T., Koiné, M.D., Pinguédewendé, S.Z., 2012. Évaluation de l’application du protocole national de traitement des cas de paludisme simple en milieu rural au Burkina Faso. Santé publique, 24 (4): 353 63.
. Maiga, B., Sacko, K., Cissouma, A., Dembélé, A., Cissé, M., Diakité, A.A., Diall, H., Touré,
A., Togo P., Doumbia, A.K., Coulibaly, O., Doumbia, A., Coulibaly, A., Konaté, D., Koné, I.,
Traoré F., 2019. Caracteristics of severe malaria in child from 0 to 5 years at the hospital of Sikasso
in Mali. Mali Medical, 2:1-5.
. Yavo, W., Ackra, K.N., Menan, E.I., Barro-Kiki, P.C., Kassi, R.R., Adjetey, T.A., Bamba, A., Koné, M., 2002. Comparative study of four malaria diagnostic techniques used in Ivory Coast. Bulletin de la Societé de Pathologie Exotique, 95 (4): 238.
. Azagoh-Kouadio, R., Enoh, S.J., Kassi, K.F., Cisse, I., Sinde, K.C., Couitchere, L., Menan, E.I.H., Oulai, S., 2017. Paludisme de l’enfant: Prise en charge au CHU de Treichville. Revue Internationale des Sciences Médicales, 19 (1): 26 30.
. Erhart L.M., Kritsanai Y., Niphon C., Nilawan B., Anintita L., Scott M.R., Steven R.M., Gasser R.A.J. & Wongsrichanalai C., 2004.- Hematologic and clinical indices of malaria in a semi-immune population of western Thailand. The American journal of tropical medicine and hygiene, 70(1): 8 14.
. Layibo, Y.A.M., Dorkenoo, A., Vovor, M., Agbo, Y., Bazamao, M., Padaro, E., Agbetiafa, K., 2014. Profil de l’hémogramme au cours de l’accès palustre simple à Plasmodium falciparum chez les enfants de 6 mois à 5 ans au Togo. Journal de La Recherche Scientifique de l’Université de Lomé, 16 (2): 347 57.
. Al-Omar, I.A., Eligail, A.M., Al-Ashban, R.M., Shah, A.H., 2010. Effect of falciparum malaria infection on blood cholesterol and platelets. Journal of Saudi Chemical Society, 14 (1): 83 89.
. Ecker, A., Lehane, A.M., Clain J., Fidock, D.A., 2012. Pfcrt and its role in antimalarial
drug resistance. Trends Parasitology, 28: 504-514.
. Kiarie, W.C., Wangai, L., Agola, E., Kimani, F.T., Hungu, C., 2015. Chloroquine sensitivity
: diminished prevalence of chloroquine-resistant gene marker pfcrt-76 13 years after cessation of
chloroquine use in Msambweni, Kenya. Malaria Journal, 14: 1-7.
. Sondo, P., Derra, K., Diallo, S., Tarnagda, Z., Kazienga, A., Zampa, O., Valéa, I.,
Sorgho, H., Owusu-Dabo, E., Ouédraogo, J.B., Guiguemdé, T.R., Tinto, H., 2016. Aretesunate-
amodiaquine and artemether-lumefantrine therapies and selection of pfcrt and pfmdr1 alleles in
Nanoro, Burkina Faso. PloS One, 15: 15-65.
. Kublin, J.G., Cortese, J.F., Njunju, E.M., Mukadam, R.A.G., Wirima, J.J., Kazembe, P.N.,
Djimdé, A.A., Kouriba, B., Taylo,r T.E., Plowe C.V., 2003. Reemergence of chloroquine-
sensitive Plasmodium falciparum malaria after cessation of chloroquine use in Malawi. The
Journal of Infectious Diseases, 187: 1870-1875.
. Krogstad, D.J., Ilya, Y.G., Dennis, E.K., Oduola, A.M., Samuel, K.M., Milhous, W.K.,
Schlesinger, P.H., 1987. Efflux of chloroquine from Plasmodium falciparum: mechanism of
chloroquine resistance. Sciences, 238 (4831): 1283 85.
. Lu F., Feng L., Meihua Z., Richard L., Culleton., Sui X., Jianxia T., Huayun Z., Guoding Z.,
Yaping G., Chao Z., Yaobao L., Weiming W., Yuanyuan C., Julin L., Xinlong H., Jun C., & Qi
G., 2017.- Return of chloroquine sensitivity to Africa? Surveillance of African Plasmodium
falciparum chloroquine resistance through malaria imported to China. Parasites & vectors. 10:
-9.
. Flegg, J., Metcalf, C., Gharbi, M., Venkatesan, M., Shewchuk, T., Hopkins, S.C., Guerin P., 2013. Trends in antimalarial drug use in Africa. American Journal of Tropical Medicine and Hygiene, 89 :857-865.
. Frosch, A.E., Laufer, M.K., Mathanga, D.P., Takala-Harrison, S., Skarbinski, J., Claassen,
C.W., Dzinjalamala, F.K., Plowe, C.V., 2014. Return of widespread chloroquinesensitive
Plasmodium falciparum to Malawi. The Journal of Infectious Diseases, 210: 1110-1114.
. Zhang, T., Xu, X., Jiang, J., Yu, C., Tian, C., Li, W., 2018. Surveillance of antimalarial
resistance molecular markers in imported Plasmodium falciparum malaria cases in Anhui, China,
-2016. American Journal of Tropical Medicine and Hygiene, 98 (4): 1132-1136.
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2022 Kouakou Brice Bla, Akou Sara Adélaïde Bognini, Aby Jerome Kouakou, Abibatou Konaté-Touré, Juliana Mensah-Akaki, Akpa Paterne Gnagne, Allico Joseph Djaman, William Yavo
This work is licensed under a Creative Commons Attribution 4.0 International License.
